Allon Therapeutics

Companies Allon Therapeutics

News Allon Therapeutics

• The United States, New Zealand & Mexico Issue Patent for New Allon Platform

  Allon Therapeutics Inc. announced that the United States, New Zealand and Mexican patent authorities have each issued composition of matter patents for a new family of peptides that the Company believes has the potential to be developed to treat neurological and neurodegenerative diseases. This new more

• Allon granted U.S. patent for neurotoxicity caused by anti-cancer drugs

  Allon Therapeutics Inc. announced that it has been granted a U.S. patent that covers the use of the Company’s neuroprotective technology platform in the treatment of peripheral neuropathy. This includes the Company’s lead drug candidate, davunetide, and pipeline product AL-309 as treatments for peri more

• Allon advances Parkinson’s disease program

  Allon Therapeutics Inc. announced the completion of its first phase of work in a preclinical Parkinson’s disease (PD) model and advancement into the second phase of work. Both phases are funded by The Michael J. Fox Foundation (MJFF) for Parkinson’s Research and carried out by Prof. Marie-Francoise more

Market studies Allon Therapeutics

• Allon Therapeutics Inc. (NPC) - Financial and Strategic SWOT Analysis Review

  Allon Therapeutics Inc. (Allon), formerly Neuro Discovery Inc. is a clinical-stage biotechnology company, engaged in the development of the first drugs that impact the progression of neurodegenerative diseases and disorders. The company is focused on developing neuroprotective therapeutic molecules more

• Neovasc Inc. (NVC) - Financial and Strategic SWOT Analysis Review

  Neovasc Inc. (Neovasc), formerly known as Medical Ventures Corp., is a medical device company engaged in the development and manufacture of cardiovascular and surgical products. The company’s devices are useful to the doctors for the treatment of a broad range of health related problems such as hear more

Websites Allon Therapeutics